C-16G2

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameC-16G2
Drug Alias NameAntimicrobial peptideC-16G2
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionCell membrane permeability enhancersMicrobiome modulators
TargetsNot applicable
Therapy Area/IndicationsDental Caries
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesC3 Jian Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesArmata Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsDental Caries

Other Information

ATC CodeN/A
Related LinksN/A